Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Menotropins
Drug ID BADD_D01380
Description Menotropins contains follicle stimulating hormone (FSH) and luteinizing hormone (LH) purified from the urine of postmenopausal women. It is used as a fertility medication that is injected either subcutaneously or intramuscularly. It is composed of LH with 2 subunits, alpha = 92 residues, beta = 121 residues and FSH with 2 subunits, alpha = 92 residues, beta=111 residues.
Indications and Usage For the treatment of female infertility
Marketing Status approved
ATC Code Not Available
DrugBank ID DB00032
KEGG ID D02692
MeSH ID D008596
PubChem ID Not Available
TTD Drug ID D04WBY
NDC Product Code 55566-7501; 67657-0004
UNII 5Y9QQM372Q
Synonyms Menotropins | Menotrophin | Gonadotropins, Human Menopausal | Human Menopausal Gonadotropins | Human Menopausal Gonadotropin | Gonadotropin, Human Menopausal | Menopausal Gonadotropin, Human | CP-90033 | CP 90033 | CP90033 | HMG Lepori | Lepori, HMG | HMG Massone | Pergonal-500 | Pergonal 500 | Pergonal500 | Menopur | HMG Ferring | Menogon | Normegon | ORG-31338 | ORG 31338 | ORG31338 | Pergonal | CP-89044 | CP 89044 | CP89044 | Humegon
Chemical Information
Molecular Formula Not Available
CAS Registry Number 9002-68-0
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Anal atresia03.04.06.001; 07.13.05.001---
Aplasia03.02.01.002; 08.03.04.003---
Arthralgia15.01.02.001--
Benign ovarian tumour16.04.03.004; 21.11.01.011---
Breast tenderness21.05.05.004---
Chills08.01.09.001; 15.05.03.016--
Congenital ectopic bladder03.06.03.002; 20.03.01.006---
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dyspnoea02.11.05.003; 22.02.01.004--
Ectopic pregnancy18.02.02.002---
Fistula15.03.02.001---
Headache17.14.01.001--
Heart disease congenital02.11.01.014; 03.07.07.001---
Hydrocephalus17.07.01.001--
Hypersensitivity10.01.03.003--
Hypospadias03.03.01.005; 20.07.04.001; 21.15.01.003---
Infection11.01.08.002---
Injection site irritation08.02.03.027; 12.07.03.027---
Injection site oedema08.02.03.024; 12.07.03.024---
Injection site reaction08.02.03.014; 12.07.03.015--
Malaise08.01.01.003--
Meningocele03.10.02.002; 17.02.10.006---
Metatarsus primus varus03.11.07.011; 15.11.07.011---
Multiple congenital abnormalities03.02.01.003---
Musculoskeletal pain15.03.04.007--
Nausea07.01.07.001--
Ovarian cyst16.04.03.001; 21.11.01.002---
The 1th Page    1 2    Next   Last    Total 2 Pages